Citi Starts Denali Therapeutics Inc. (DNLI) at Buy, 'Deep CNS Pipeline and Differentiated Platform Approaching Value Inflection Point'

December 12, 2023 4:03 PM EST Send to a Friend
(Updated - December 12, 2023 4:12 PM EST)

Citi analyst David Hoang initiates coverage on Denali Therapeutics Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login